| |
| |
|
| Insider
Information: |
Ginascol John F |
| Relationship: |
|
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
118,380 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,536,442 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
118,380 |
|
|
| Total
Value |
$12,536,442 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
|
2023-03-01 |
118,380 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-03-01 |
4 |
S |
$100.70 |
$94,960 |
D/D |
(943) |
118,380 |
0 |
% |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-02-28 |
4 |
D |
$99.77 |
$684,322 |
D/D |
(6,859) |
119,323 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,270 |
126,182 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-12-13 |
4 |
S |
$112.32 |
$1,235,520 |
D/D |
(11,000) |
111,912 |
0 |
% |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-06-03 |
4 |
D |
$117.51 |
$207,758 |
D/D |
(1,768) |
122,912 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-02-28 |
4 |
D |
$122.41 |
$719,281 |
D/D |
(5,876) |
125,045 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
17,247 |
130,921 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-10-27 |
4 |
D |
$128.13 |
$3,791,110 |
D/D |
(29,588) |
113,674 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-10-27 |
4 |
OE |
$47.00 |
$2,148,323 |
D/D |
45,709 |
143,262 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-06-03 |
4 |
D |
$106.90 |
$188,999 |
D/D |
(1,768) |
97,553 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-03-01 |
4 |
S |
$118.16 |
$43,128 |
D/D |
(365) |
124,680 |
0 |
% |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-03-01 |
4 |
S |
$120.61 |
$42,455 |
D/D |
(352) |
99,321 |
0 |
% |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-26 |
4 |
D |
$121.58 |
$575,803 |
D/D |
(4,736) |
99,673 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,406 |
104,409 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-09-01 |
4 |
D |
$109.47 |
$5,229,601 |
D/D |
(47,772) |
89,003 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-09-01 |
4 |
OE |
$38.40 |
$3,111,584 |
D/D |
72,098 |
136,775 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-06-03 |
4 |
D |
$92.62 |
$163,752 |
D/D |
(1,768) |
64,677 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-04-21 |
4 |
OE |
$38.40 |
$2,426,880 |
D/D |
63,200 |
129,645 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-04-21 |
4 |
S |
$95.57 |
$6,067,051 |
D/D |
(63,200) |
66,445 |
0 |
% |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-03-02 |
4 |
S |
$77.58 |
$512,805 |
D/D |
(6,606) |
66,445 |
0 |
% |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-02-28 |
4 |
D |
$79.19 |
$177,861 |
D/D |
(2,246) |
73,051 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
18,855 |
75,297 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice PresidentOffice |
• – – |
2019-06-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,617 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,967 |
60,584 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
